Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :22456196
Publication Date : //

RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.


Recently, we have identified serum response factor (SRF) as a mediator of clinically relevant androgen receptor (AR) action in prostate cancer (PCa). Genes that rely on SRF for androgen responsiveness represent a small fraction of androgen-regulated genes, but distinguish benign from malignant prostate, correlate with aggressive disease, and are associated with biochemical recurrence. Thus, understanding the mechanism(s) by which SRF conveys androgen regulation to its target genes may provide novel opportunities to target clinically relevant androgen signaling. Here, we show that the small GTPase ras homolog family member A (RhoA) mediates androgen-responsiveness of more than half of SRF target genes. Interference with expression of RhoA, activity of the RhoA effector Rho-associated coiled-coil containing protein kinase 1 (ROCK), and actin polymerization necessary for nuclear translocation of the SRF cofactor megakaryocytic acute leukemia (MAL) prevented full androgen regulation of SRF target genes. Androgen treatment induced RhoA activation, increased the nuclear content of MAL, and led to MAL recruitment to the promoter of the SRF target gene FHL2. In clinical specimens RhoA expression was higher in PCa cells than benign prostate cells, and elevated RhoA expression levels were associated with aggressive disease features and decreased disease-free survival after radical prostatectomy. Overexpression of RhoA markedly increased the androgen-responsiveness of select SRF target genes, in a manner that depends on its GTPase activity. The use of isogenic cell lines and a xenograft model that mimics the transition from androgen-stimulated to castration-recurrent PCa indicated that RhoA levels are not altered during disease progression, suggesting that RhoA expression levels in the primary tumor determine disease aggressiveness. Androgen-responsiveness of SRF target genes in castration-recurrent PCa cells continued to rely on AR, RhoA, SRF, and MAL and the presence of intact SRF binding sites. Silencing of RhoA, use of Rho-associated coiled-coil containing protein kinase 1 inhibitors, or an inhibitor of SRF-MAL interaction attenuated (androgen-regulated) cell viability and blunted PCa cell migration. Taken together, these studies demonstrate that the RhoA signaling axis mediates clinically relevant AR action in PCa.

Authors : Schmidt Lucy J , Duncan Kelly , Yadav Neelu , Regan Kevin M , Verone Alissa R , Lohse Christine M , Pop Elena A , Attwood Kristopher , Wilding Gregory , Mohler James L , Sebo Thomas J , Tindall Donald J , Heemers Hannelore V ,

Related products :

Catalog number Product name Quantity
EIAAB40264 Homo sapiens,Human,Metalloreductase STEAP2,PCANAP1,Prostate cancer-associated protein 1,Protein upregulated in metastatic prostate cancer,PUMPCn,Six-transmembrane epithelial antigen of prostate 2,SixT
orb61223 Bicalutamide Bicalutamide (marketed as Casodex, Cosudex, Calutide, Kalumid) is an oral non-steroidal anti-androgen used in the treatment of prostate cancer and hirsutism. For research use only. 100 mg
Prostate - PRC481 Prostate cancer tissue array contains 17 cases of pancreatic tumors and 7 cases of normal and reactive prostate tissues. 2mm
orb84796 IL21 protein IL21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigenspecific responses of immune cells. The biological effec 10
orb82622 Rat IL21 protein IL21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. The biological 2
PR207b High_density prostate cancer (1_4 grade) and normal prostate tissue array, 70 cases_208 cores
25-042 The homeodomain-containing transcription factor NKX3-1 is a putative prostate tumor suppressor that is expressed in a largely prostate-specific and androgen-regulated manner. Loss of NKX3-1 protein ex 0.05 mg
PR721 Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases_72 cores
PR2085b High_density (208 core) prostate adenocarcinoma (I_4 grade) and normal prostate (from autopsy and cancer adjacent) tissue BLOCK
PR208 High_density (70 cases_208 cores), multiple prostate cancer (1_4 grade), normal prostate and placenta tissue array
PR2085a High_density (114 cases_208 cores) prostate adenocarcinoma (I_4 grade) and normal prostate (from autopsy and cancer adjacent) tissue array
PR721 Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases_72 cores; ihc Anti-Actin confirmed
PR481 Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases_48 cores, with grades, stages and Gleason scores
9-80287 Rat Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture 1 x 100 ml
9-25080 Rat Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture 5 x 100 ml
9-26080 Rat Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture set
2-82580 Rat Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture Kit
4-28287 Rat Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture Kit
7-15257 Rat Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture Kit
9-47099 Human Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture set
4-28197 Mouse Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture Kit
9-80197 Mouse Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture 1 x 100 ml
9-46099 Human Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture 5 x 100 ml
7-15089 Human Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture Kit
4-28099 Human Prostate PrimaCell™: Normal Prostate Epithelial Cells, primary cell culture Kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur